Francis M. Cuss

4.2k total citations
49 papers, 2.3k citations indexed

About

Francis M. Cuss is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Francis M. Cuss has authored 49 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Physiology, 23 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Francis M. Cuss's work include Asthma and respiratory diseases (27 papers), Respiratory and Cough-Related Research (16 papers) and Inhalation and Respiratory Drug Delivery (9 papers). Francis M. Cuss is often cited by papers focused on Asthma and respiratory diseases (27 papers), Respiratory and Cough-Related Research (16 papers) and Inhalation and Respiratory Drug Delivery (9 papers). Francis M. Cuss collaborates with scholars based in United Kingdom, United States and Belgium. Francis M. Cuss's co-authors include Peter J. Barnes, James Palmer, Robert W. Egan, CM Dixon, Richard W. Chapman, Shelby P. Umland, R W Fuller, Jamie Palmer, Ashley Woodcock and Huib A.M. Kerstjens and has published in prestigious journals such as Nature, Nature Reviews Drug Discovery and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Francis M. Cuss

46 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francis M. Cuss United Kingdom 24 1.5k 780 512 476 432 49 2.3k
Michael A. Kaliner United States 23 638 0.4× 316 0.4× 205 0.4× 276 0.6× 441 1.0× 37 1.5k
M Fujimura Japan 29 1.6k 1.1× 1.6k 2.1× 297 0.6× 304 0.6× 143 0.3× 128 2.9k
Harm Maarsingh Netherlands 29 1.3k 0.9× 894 1.1× 186 0.4× 827 1.7× 103 0.2× 68 2.5k
C M Lilly United States 18 1.1k 0.7× 546 0.7× 163 0.3× 201 0.4× 142 0.3× 26 1.7k
Akihiro Nomura Japan 26 715 0.5× 739 0.9× 104 0.2× 741 1.6× 84 0.2× 64 2.2k
A E Redington United Kingdom 17 1.4k 0.9× 829 1.1× 80 0.2× 157 0.3× 230 0.5× 25 2.0k
Xiaoqun Qin China 21 357 0.2× 373 0.5× 175 0.3× 466 1.0× 99 0.2× 108 1.4k
S. Nicholas Mason United States 17 568 0.4× 456 0.6× 90 0.2× 447 0.9× 28 0.1× 24 1.9k
James W. Voltz United States 17 368 0.2× 512 0.7× 104 0.2× 603 1.3× 52 0.1× 18 1.7k
Malcolm Begg United Kingdom 20 215 0.1× 194 0.2× 323 0.6× 397 0.8× 41 0.1× 43 1.6k

Countries citing papers authored by Francis M. Cuss

Since Specialization
Citations

This map shows the geographic impact of Francis M. Cuss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis M. Cuss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis M. Cuss more than expected).

Fields of papers citing papers by Francis M. Cuss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francis M. Cuss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis M. Cuss. The network helps show where Francis M. Cuss may publish in the future.

Co-authorship network of co-authors of Francis M. Cuss

This figure shows the co-authorship network connecting the top 25 collaborators of Francis M. Cuss. A scholar is included among the top collaborators of Francis M. Cuss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francis M. Cuss. Francis M. Cuss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cuss, Francis M., et al.. (2016). Organizational effectiveness: a key to R&D productivity. Nature Reviews Drug Discovery. 15(7). 441–442. 8 indexed citations
2.
Fuller, Richard W., Caroline Dixon, Francis M. Cuss, & Peter J. Barnes. (2015). Bradykinin-induced Bronchoconstriction in Humans. American Review of Respiratory Disease. 3 indexed citations
3.
Kips, Johan, Brian O’Connor, Stephen J. Langley, et al.. (2003). Effect of SCH55700, a Humanized Anti-Human Interleukin-5 Antibody, in Severe Persistent Asthma: A Pilot Study. American Journal of Respiratory and Critical Care Medicine. 167(12). 1655–1659. 378 indexed citations
4.
McLeod, Robbie L., Leonard E. Parra, Galen Carey, et al.. (2001). Nociceptin inhibits cough in the guinea‐pig by activation of ORL1 receptors. British Journal of Pharmacology. 132(6). 1175–1178. 84 indexed citations
5.
Rizzo, Charles A., et al.. (2001). Synergistic antiallergic activity of combined histamine H1- and cysteinyl leukotriene1-receptor blockade in human bronchus. Life Sciences. 68(25). 2825–2834. 15 indexed citations
6.
Hey, John A., M B Affrime, Barton Cobert, William Kreutner, & Francis M. Cuss. (1999). Cardiovascular profile of loratadine. Clinical & Experimental Allergy. 29(S3). 197–199. 7 indexed citations
7.
Cuss, Francis M., et al.. (1997). Inhibition of interleukin‐5 with a monoclonal antibody attenuates allergic inflammation. Allergy. 52(8). 787–794. 28 indexed citations
8.
Bronsky, Edwin A., Donald W. Aaronson, Robert Berkowitz, et al.. (1997). Dose Ranging Study of Mometasone Furoate (Nasonex) in Seasonal Allergic Rhinitis. Annals of Allergy Asthma & Immunology. 79(1). 51–56. 55 indexed citations
9.
Egan, Robert W., Shelby P. Umland, Francis M. Cuss, & Richard W. Chapman. (1996). Biology of interleukin-5 and its relevance to allergic disease. Allergy. 51(2). 71–81. 7 indexed citations
10.
Brannan, Melvin D., et al.. (1996). 62 Lack of systemic activity with intranasal mometasone furoate. Journal of Allergy and Clinical Immunology. 97(1). 198–198. 46 indexed citations
11.
Zangrilli, James, Joseph R. Shaver, Charles G. Garlisi, et al.. (1995). SVCAM-1 Levels after Segmental Antigen Challenge Correlate with Eosinophil Influx, IL-4 and IL-5 Production, and the Late Phase Response. American Journal of Respiratory and Critical Care Medicine. 151(5). 1346–1353. 87 indexed citations
12.
Ciprandi, Giorgio, S. Buscaglia, Emanuela Marchesi, et al.. (1993). Protective Effect of Loratadine on Late Phase Reaction Induced by Conjunctival Provocation Test. International Archives of Allergy and Immunology. 100(2). 185–189. 42 indexed citations
13.
Chung, Kian Fan, Francis M. Cuss, & Peter J. Barnes. (1989). Platelet Activating Factor: Effects on Bronchomotor Tone and Bronchial Responsiveness in Human Beings. Allergy and Asthma Proceedings. 10(5). 333–337. 6 indexed citations
14.
Cuss, Francis M.. (1988). Is Choice of Drug Delivery as Important as Choice of Drug in Childhood Asthma?. Birkhäuser Basel eBooks. 23. 277–283. 2 indexed citations
15.
Cuss, Francis M., et al.. (1986). Tuberculosis in renal failure: a high incidence in patients born in the Third World.. PubMed. 25(3). 129–33. 23 indexed citations
16.
Cuss, Francis M., Jamie Palmer, & Peter J. Barnes. (1985). Rapid estimation of plasma theophylline concentrations.. BMJ. 291(6492). 384–384. 2 indexed citations
17.
Barnes, Peter J., Francis M. Cuss, & James Palmer. (1985). The effect of airway epithelium on smooth muscle contractility in bovine trachea. British Journal of Pharmacology. 86(3). 685–691. 228 indexed citations
18.
Palmer, Jamie, Francis M. Cuss, & Peter J. Barnes. (1985). The Effect of Vasoactive Intestinal Peptide on Human Airway Smooth Muscle in-vitro. Clinical Science. 68(s11). 58P–58P. 1 indexed citations
19.
Cuss, Francis M. & Peter J. Barnes. (1985). The effect of inhaled nifedipine on bronchial reactivity to histamine in man. Journal of Allergy and Clinical Immunology. 76(5). 718–723. 20 indexed citations
20.
Cuss, Francis M., et al.. (1984). Cardiac arrest after reversal of effects of opiates with naloxone.. BMJ. 288(6414). 363–364. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026